Target intelligence / Profile preview

MT-ND4 pseudogene 22 (MTND4P22)

Target
MTND4P22
Molecular classification
Other (pseudogene); not a member of protein, enzyme, receptor, transporter, or transcription factor classes
01

Overview

MT-ND4 pseudogene 22 (MTND4P22) is a nuclear pseudogene derived from mitochondrial DNA and ancestrally related to the MT-ND4 gene, which encodes a core subunit of complex I in the mitochondrial electron transport chain. Unlike the functional mitochondrial MT-ND4 gene, which is involved in ATP production and implicated in diseases such as Leber hereditary optic neuropathy, pseudogenes such as MTND4P22 do not produce functional proteins and are not considered molecular targets for drugs, therapeutic intervention, or disease monitoring[7]. As such, MTND4P22 has no direct biological or clinical relevance, is not a target of any drugs, and does not have associated disease roles or biomarkers. Key clarification: MTND4P22 is not the same as the functional MT-ND4 gene or NADH dehydrogenase 4 protein (ND4), which is a critical component of mitochondrial electron transport and involved in several diseases[1][5][6]. MTND4P22 is nonfunctional and considered only as a genomic relic, with no known role in health or disease[7].

Other names
MTND4P22mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 22

Beyond the preview

Go deeper on MT-ND4 pseudogene 22 (MTND4P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND4 pseudogene 22 (MTND4P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call